Schedule 13D ownership disclosure

LB Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 50180M108

Event date: 2025-09-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deep Track Biotechnology Master Fund, Ltd.

    Shares: 2,686,138.00 · Class: 12.0%

  • Deep Track Special Opportunities Fund, LP

    Shares: 666,666.00 · Class: 3.0%

  • Deep Track Capital, LPReported CIK 0001856083

    Shares: 3,352,804.00 · Class: 14.9%

  • David Kroin

    Shares: 3,352,804.00 · Class: 14.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-209153
Form type
SCHEDULE 13D
Filer
Deep Track Capital, LP
CIK
CIK 1856083
Filed
Sep 19, 2025
Reporting period
Sep 12, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub